nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—CYP1A2—Imiquimod—skin cancer	0.0938	0.142	CbGbCtD
Citalopram—CYP2C19—Vismodegib—skin cancer	0.0705	0.107	CbGbCtD
Citalopram—CYP2E1—Dacarbazine—skin cancer	0.0681	0.103	CbGbCtD
Citalopram—ABCB1—Vismodegib—skin cancer	0.0569	0.0862	CbGbCtD
Citalopram—CYP1A2—Vemurafenib—skin cancer	0.0514	0.078	CbGbCtD
Citalopram—CYP3A4—Imiquimod—skin cancer	0.0492	0.0745	CbGbCtD
Citalopram—CYP3A4—Temozolomide—skin cancer	0.0492	0.0745	CbGbCtD
Citalopram—CYP2D6—Vemurafenib—skin cancer	0.0424	0.0642	CbGbCtD
Citalopram—CYP1A2—Dacarbazine—skin cancer	0.0394	0.0597	CbGbCtD
Citalopram—CYP3A4—Vismodegib—skin cancer	0.0341	0.0517	CbGbCtD
Citalopram—ABCB1—Dactinomycin—skin cancer	0.0299	0.0453	CbGbCtD
Citalopram—CYP3A4—Vemurafenib—skin cancer	0.0269	0.0408	CbGbCtD
Citalopram—CYP1A2—Fluorouracil—skin cancer	0.0231	0.035	CbGbCtD
Citalopram—ABCB1—Docetaxel—skin cancer	0.0154	0.0234	CbGbCtD
Citalopram—CYP3A4—Docetaxel—skin cancer	0.00924	0.014	CbGbCtD
Citalopram—HRH1—nose—skin cancer	0.00161	0.188	CbGeAlD
Citalopram—SLC6A3—nerve—skin cancer	0.000794	0.0926	CbGeAlD
Citalopram—SLC6A2—nerve—skin cancer	0.00064	0.0747	CbGeAlD
Citalopram—CYP1A2—nipple—skin cancer	0.000279	0.0326	CbGeAlD
Citalopram—HRH1—nipple—skin cancer	0.000262	0.0305	CbGeAlD
Citalopram—ADRA1A—epithelium—skin cancer	0.000228	0.0266	CbGeAlD
Citalopram—HTR2C—female reproductive system—skin cancer	0.000218	0.0254	CbGeAlD
Citalopram—SLC6A4—female reproductive system—skin cancer	0.000207	0.0241	CbGeAlD
Citalopram—CHRM1—female reproductive system—skin cancer	0.000206	0.024	CbGeAlD
Citalopram—ABCB1—blood vessel—skin cancer	0.000198	0.0231	CbGeAlD
Citalopram—SLC6A3—head—skin cancer	0.000188	0.022	CbGeAlD
Citalopram—HRH1—connective tissue—skin cancer	0.000186	0.0216	CbGeAlD
Citalopram—HTR2C—head—skin cancer	0.000182	0.0212	CbGeAlD
Citalopram—SLC6A2—female reproductive system—skin cancer	0.000182	0.0212	CbGeAlD
Citalopram—HRH1—epithelium—skin cancer	0.000176	0.0206	CbGeAlD
Citalopram—ADRA1A—lymphoid tissue—skin cancer	0.000175	0.0204	CbGeAlD
Citalopram—SLC6A4—head—skin cancer	0.000173	0.0201	CbGeAlD
Citalopram—CHRM1—head—skin cancer	0.000172	0.0201	CbGeAlD
Citalopram—CYP2B6—skin of body—skin cancer	0.000172	0.02	CbGeAlD
Citalopram—Malaise—Dactinomycin—skin cancer	0.000155	0.000468	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000155	0.000467	CcSEcCtD
Citalopram—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000155	0.000467	CcSEcCtD
Citalopram—Cramp muscle—Docetaxel—skin cancer	0.000155	0.000467	CcSEcCtD
Citalopram—Leukopenia—Dactinomycin—skin cancer	0.000154	0.000464	CcSEcCtD
Citalopram—Nasopharyngitis—Docetaxel—skin cancer	0.000154	0.000463	CcSEcCtD
Citalopram—HRH1—mammalian vulva—skin cancer	0.000153	0.0178	CbGeAlD
Citalopram—Dysgeusia—Temozolomide—skin cancer	0.000153	0.00046	CcSEcCtD
Citalopram—Asthenia—Imiquimod—skin cancer	0.000152	0.000459	CcSEcCtD
Citalopram—Confusional state—Bleomycin—skin cancer	0.000152	0.000458	CcSEcCtD
Citalopram—SLC6A2—head—skin cancer	0.000152	0.0177	CbGeAlD
Citalopram—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000152	0.000457	CcSEcCtD
Citalopram—Oedema—Bleomycin—skin cancer	0.000151	0.000454	CcSEcCtD
Citalopram—Anaphylactic shock—Bleomycin—skin cancer	0.000151	0.000454	CcSEcCtD
Citalopram—Back pain—Temozolomide—skin cancer	0.000151	0.000454	CcSEcCtD
Citalopram—Pruritus—Imiquimod—skin cancer	0.00015	0.000452	CcSEcCtD
Citalopram—Infection—Bleomycin—skin cancer	0.00015	0.000451	CcSEcCtD
Citalopram—Dysphagia—Docetaxel—skin cancer	0.000149	0.000448	CcSEcCtD
Citalopram—Nausea—Vemurafenib—skin cancer	0.000148	0.000445	CcSEcCtD
Citalopram—Thrombocytopenia—Bleomycin—skin cancer	0.000148	0.000445	CcSEcCtD
Citalopram—Arrhythmia—Fluorouracil—skin cancer	0.000147	0.000444	CcSEcCtD
Citalopram—Vision blurred—Temozolomide—skin cancer	0.000147	0.000442	CcSEcCtD
Citalopram—Myalgia—Dactinomycin—skin cancer	0.000147	0.000442	CcSEcCtD
Citalopram—Bronchospasm—Docetaxel—skin cancer	0.000146	0.000441	CcSEcCtD
Citalopram—Tremor—Temozolomide—skin cancer	0.000146	0.00044	CcSEcCtD
Citalopram—Alopecia—Fluorouracil—skin cancer	0.000146	0.000439	CcSEcCtD
Citalopram—Diarrhoea—Imiquimod—skin cancer	0.000145	0.000437	CcSEcCtD
Citalopram—Discomfort—Dactinomycin—skin cancer	0.000145	0.000436	CcSEcCtD
Citalopram—Angina pectoris—Docetaxel—skin cancer	0.000145	0.000436	CcSEcCtD
Citalopram—Ill-defined disorder—Temozolomide—skin cancer	0.000145	0.000435	CcSEcCtD
Citalopram—Anaemia—Temozolomide—skin cancer	0.000144	0.000434	CcSEcCtD
Citalopram—Anorexia—Bleomycin—skin cancer	0.000144	0.000433	CcSEcCtD
Citalopram—Erythema—Fluorouracil—skin cancer	0.000144	0.000432	CcSEcCtD
Citalopram—Agitation—Temozolomide—skin cancer	0.000143	0.000431	CcSEcCtD
Citalopram—Angioedema—Temozolomide—skin cancer	0.000142	0.000429	CcSEcCtD
Citalopram—ADRA1A—head—skin cancer	0.000141	0.0165	CbGeAlD
Citalopram—Pancytopenia—Docetaxel—skin cancer	0.000141	0.000425	CcSEcCtD
Citalopram—Hypotension—Bleomycin—skin cancer	0.000141	0.000424	CcSEcCtD
Citalopram—Oedema—Dactinomycin—skin cancer	0.000141	0.000424	CcSEcCtD
Citalopram—Malaise—Temozolomide—skin cancer	0.000141	0.000423	CcSEcCtD
Citalopram—Dizziness—Imiquimod—skin cancer	0.00014	0.000423	CcSEcCtD
Citalopram—Vertigo—Temozolomide—skin cancer	0.00014	0.000422	CcSEcCtD
Citalopram—Infection—Dactinomycin—skin cancer	0.00014	0.000421	CcSEcCtD
Citalopram—Leukopenia—Temozolomide—skin cancer	0.000139	0.00042	CcSEcCtD
Citalopram—CYP2B6—lymphoid tissue—skin cancer	0.000139	0.0162	CbGeAlD
Citalopram—Palpitations—Temozolomide—skin cancer	0.000138	0.000415	CcSEcCtD
Citalopram—Thrombocytopenia—Dactinomycin—skin cancer	0.000138	0.000415	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000137	0.000414	CcSEcCtD
Citalopram—Cough—Temozolomide—skin cancer	0.000136	0.00041	CcSEcCtD
Citalopram—Paraesthesia—Bleomycin—skin cancer	0.000135	0.000408	CcSEcCtD
Citalopram—Weight increased—Docetaxel—skin cancer	0.000135	0.000408	CcSEcCtD
Citalopram—Vision blurred—Fluorouracil—skin cancer	0.000135	0.000408	CcSEcCtD
Citalopram—Convulsion—Temozolomide—skin cancer	0.000135	0.000407	CcSEcCtD
Citalopram—Vomiting—Imiquimod—skin cancer	0.000135	0.000406	CcSEcCtD
Citalopram—Weight decreased—Docetaxel—skin cancer	0.000135	0.000405	CcSEcCtD
Citalopram—Hypertension—Temozolomide—skin cancer	0.000135	0.000405	CcSEcCtD
Citalopram—Dyspnoea—Bleomycin—skin cancer	0.000134	0.000405	CcSEcCtD
Citalopram—Anorexia—Dactinomycin—skin cancer	0.000134	0.000404	CcSEcCtD
Citalopram—CYP2B6—female reproductive system—skin cancer	0.000134	0.0156	CbGeAlD
Citalopram—Rash—Imiquimod—skin cancer	0.000134	0.000403	CcSEcCtD
Citalopram—Dermatitis—Imiquimod—skin cancer	0.000134	0.000403	CcSEcCtD
Citalopram—Pneumonia—Docetaxel—skin cancer	0.000133	0.000402	CcSEcCtD
Citalopram—Headache—Imiquimod—skin cancer	0.000133	0.0004	CcSEcCtD
Citalopram—Anaemia—Fluorouracil—skin cancer	0.000133	0.0004	CcSEcCtD
Citalopram—Arthralgia—Temozolomide—skin cancer	0.000133	0.0004	CcSEcCtD
Citalopram—Myalgia—Temozolomide—skin cancer	0.000133	0.0004	CcSEcCtD
Citalopram—Infestation NOS—Docetaxel—skin cancer	0.000133	0.000399	CcSEcCtD
Citalopram—Infestation—Docetaxel—skin cancer	0.000133	0.000399	CcSEcCtD
Citalopram—Anxiety—Temozolomide—skin cancer	0.000132	0.000398	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000132	0.000397	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000131	0.000396	CcSEcCtD
Citalopram—Discomfort—Temozolomide—skin cancer	0.000131	0.000395	CcSEcCtD
Citalopram—Decreased appetite—Bleomycin—skin cancer	0.000131	0.000395	CcSEcCtD
Citalopram—HRH1—female reproductive system—skin cancer	0.000131	0.0153	CbGeAlD
Citalopram—Acute coronary syndrome—Docetaxel—skin cancer	0.000131	0.000394	CcSEcCtD
Citalopram—CYP2E1—lymphoid tissue—skin cancer	0.00013	0.0152	CbGeAlD
Citalopram—Myocardial infarction—Docetaxel—skin cancer	0.00013	0.000392	CcSEcCtD
Citalopram—Neuropathy peripheral—Docetaxel—skin cancer	0.00013	0.000392	CcSEcCtD
Citalopram—Dry mouth—Temozolomide—skin cancer	0.00013	0.000391	CcSEcCtD
Citalopram—Jaundice—Docetaxel—skin cancer	0.000129	0.000389	CcSEcCtD
Citalopram—Stomatitis—Docetaxel—skin cancer	0.000129	0.000389	CcSEcCtD
Citalopram—Pain—Bleomycin—skin cancer	0.000129	0.000388	CcSEcCtD
Citalopram—Conjunctivitis—Docetaxel—skin cancer	0.000129	0.000388	CcSEcCtD
Citalopram—Leukopenia—Fluorouracil—skin cancer	0.000128	0.000387	CcSEcCtD
Citalopram—Confusional state—Temozolomide—skin cancer	0.000128	0.000386	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000128	0.000386	CcSEcCtD
Citalopram—Anaphylactic shock—Temozolomide—skin cancer	0.000127	0.000383	CcSEcCtD
Citalopram—Oedema—Temozolomide—skin cancer	0.000127	0.000383	CcSEcCtD
Citalopram—Infection—Temozolomide—skin cancer	0.000126	0.000381	CcSEcCtD
Citalopram—Nausea—Imiquimod—skin cancer	0.000126	0.00038	CcSEcCtD
Citalopram—CYP2E1—female reproductive system—skin cancer	0.000126	0.0147	CbGeAlD
Citalopram—Hepatobiliary disease—Docetaxel—skin cancer	0.000125	0.000378	CcSEcCtD
Citalopram—Epistaxis—Docetaxel—skin cancer	0.000125	0.000377	CcSEcCtD
Citalopram—Nervous system disorder—Temozolomide—skin cancer	0.000125	0.000376	CcSEcCtD
Citalopram—Thrombocytopenia—Temozolomide—skin cancer	0.000124	0.000375	CcSEcCtD
Citalopram—Convulsion—Fluorouracil—skin cancer	0.000124	0.000375	CcSEcCtD
Citalopram—Feeling abnormal—Bleomycin—skin cancer	0.000124	0.000374	CcSEcCtD
Citalopram—Agranulocytosis—Docetaxel—skin cancer	0.000124	0.000373	CcSEcCtD
Citalopram—Skin disorder—Temozolomide—skin cancer	0.000124	0.000372	CcSEcCtD
Citalopram—Hyperhidrosis—Temozolomide—skin cancer	0.000123	0.00037	CcSEcCtD
Citalopram—Chest pain—Fluorouracil—skin cancer	0.000122	0.000368	CcSEcCtD
Citalopram—Myalgia—Fluorouracil—skin cancer	0.000122	0.000368	CcSEcCtD
Citalopram—Decreased appetite—Dactinomycin—skin cancer	0.000122	0.000368	CcSEcCtD
Citalopram—Fatigue—Dactinomycin—skin cancer	0.000121	0.000365	CcSEcCtD
Citalopram—Anorexia—Temozolomide—skin cancer	0.000121	0.000365	CcSEcCtD
Citalopram—Discomfort—Fluorouracil—skin cancer	0.000121	0.000364	CcSEcCtD
Citalopram—Pain—Dactinomycin—skin cancer	0.00012	0.000362	CcSEcCtD
Citalopram—Urticaria—Bleomycin—skin cancer	0.00012	0.000361	CcSEcCtD
Citalopram—Haemoglobin—Docetaxel—skin cancer	0.00012	0.00036	CcSEcCtD
Citalopram—Rhinitis—Docetaxel—skin cancer	0.000119	0.000359	CcSEcCtD
Citalopram—Body temperature increased—Bleomycin—skin cancer	0.000119	0.000359	CcSEcCtD
Citalopram—Haemorrhage—Docetaxel—skin cancer	0.000119	0.000359	CcSEcCtD
Citalopram—Hepatitis—Docetaxel—skin cancer	0.000119	0.000359	CcSEcCtD
Citalopram—Hypoaesthesia—Docetaxel—skin cancer	0.000118	0.000357	CcSEcCtD
Citalopram—Confusional state—Fluorouracil—skin cancer	0.000118	0.000356	CcSEcCtD
Citalopram—Pharyngitis—Docetaxel—skin cancer	0.000118	0.000356	CcSEcCtD
Citalopram—Urinary tract disorder—Docetaxel—skin cancer	0.000118	0.000354	CcSEcCtD
Citalopram—Oedema peripheral—Docetaxel—skin cancer	0.000117	0.000353	CcSEcCtD
Citalopram—Anaphylactic shock—Fluorouracil—skin cancer	0.000117	0.000353	CcSEcCtD
Citalopram—Oedema—Fluorouracil—skin cancer	0.000117	0.000353	CcSEcCtD
Citalopram—Connective tissue disorder—Docetaxel—skin cancer	0.000117	0.000352	CcSEcCtD
Citalopram—Urethral disorder—Docetaxel—skin cancer	0.000117	0.000351	CcSEcCtD
Citalopram—Infection—Fluorouracil—skin cancer	0.000116	0.000351	CcSEcCtD
Citalopram—Feeling abnormal—Dactinomycin—skin cancer	0.000116	0.000349	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000116	0.000349	CcSEcCtD
Citalopram—Insomnia—Temozolomide—skin cancer	0.000115	0.000346	CcSEcCtD
Citalopram—Gastrointestinal pain—Dactinomycin—skin cancer	0.000115	0.000346	CcSEcCtD
Citalopram—Nervous system disorder—Fluorouracil—skin cancer	0.000115	0.000346	CcSEcCtD
Citalopram—Thrombocytopenia—Fluorouracil—skin cancer	0.000115	0.000346	CcSEcCtD
Citalopram—Visual impairment—Docetaxel—skin cancer	0.000115	0.000346	CcSEcCtD
Citalopram—Tachycardia—Fluorouracil—skin cancer	0.000114	0.000344	CcSEcCtD
Citalopram—Paraesthesia—Temozolomide—skin cancer	0.000114	0.000344	CcSEcCtD
Citalopram—Dyspnoea—Temozolomide—skin cancer	0.000113	0.000341	CcSEcCtD
Citalopram—Somnolence—Temozolomide—skin cancer	0.000113	0.000341	CcSEcCtD
Citalopram—Erythema multiforme—Docetaxel—skin cancer	0.000113	0.000339	CcSEcCtD
Citalopram—CYP2B6—head—skin cancer	0.000112	0.0131	CbGeAlD
Citalopram—Dyspepsia—Temozolomide—skin cancer	0.000112	0.000337	CcSEcCtD
Citalopram—Anorexia—Fluorouracil—skin cancer	0.000112	0.000336	CcSEcCtD
Citalopram—Eye disorder—Docetaxel—skin cancer	0.000111	0.000335	CcSEcCtD
Citalopram—Abdominal pain—Dactinomycin—skin cancer	0.000111	0.000335	CcSEcCtD
Citalopram—Body temperature increased—Dactinomycin—skin cancer	0.000111	0.000335	CcSEcCtD
Citalopram—Hypersensitivity—Bleomycin—skin cancer	0.000111	0.000335	CcSEcCtD
Citalopram—Decreased appetite—Temozolomide—skin cancer	0.000111	0.000333	CcSEcCtD
Citalopram—Cardiac disorder—Docetaxel—skin cancer	0.00011	0.000333	CcSEcCtD
Citalopram—Flushing—Docetaxel—skin cancer	0.00011	0.000333	CcSEcCtD
Citalopram—Gastrointestinal disorder—Temozolomide—skin cancer	0.00011	0.000331	CcSEcCtD
Citalopram—Fatigue—Temozolomide—skin cancer	0.00011	0.00033	CcSEcCtD
Citalopram—Hypotension—Fluorouracil—skin cancer	0.000109	0.00033	CcSEcCtD
Citalopram—HRH1—head—skin cancer	0.000109	0.0128	CbGeAlD
Citalopram—Pain—Temozolomide—skin cancer	0.000109	0.000328	CcSEcCtD
Citalopram—Constipation—Temozolomide—skin cancer	0.000109	0.000328	CcSEcCtD
Citalopram—Asthenia—Bleomycin—skin cancer	0.000108	0.000326	CcSEcCtD
Citalopram—Angiopathy—Docetaxel—skin cancer	0.000108	0.000325	CcSEcCtD
Citalopram—Immune system disorder—Docetaxel—skin cancer	0.000108	0.000324	CcSEcCtD
Citalopram—Mediastinal disorder—Docetaxel—skin cancer	0.000107	0.000323	CcSEcCtD
Citalopram—Chills—Docetaxel—skin cancer	0.000107	0.000322	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000107	0.000322	CcSEcCtD
Citalopram—Pruritus—Bleomycin—skin cancer	0.000107	0.000321	CcSEcCtD
Citalopram—SLC6A2—lymph node—skin cancer	0.000106	0.0124	CbGeAlD
Citalopram—Arrhythmia—Docetaxel—skin cancer	0.000106	0.00032	CcSEcCtD
Citalopram—Insomnia—Fluorouracil—skin cancer	0.000106	0.000319	CcSEcCtD
Citalopram—Paraesthesia—Fluorouracil—skin cancer	0.000105	0.000317	CcSEcCtD
Citalopram—Alopecia—Docetaxel—skin cancer	0.000105	0.000317	CcSEcCtD
Citalopram—CYP2E1—head—skin cancer	0.000105	0.0123	CbGeAlD
Citalopram—Feeling abnormal—Temozolomide—skin cancer	0.000105	0.000316	CcSEcCtD
Citalopram—Dyspnoea—Fluorouracil—skin cancer	0.000104	0.000315	CcSEcCtD
Citalopram—Mental disorder—Docetaxel—skin cancer	0.000104	0.000314	CcSEcCtD
Citalopram—Somnolence—Fluorouracil—skin cancer	0.000104	0.000314	CcSEcCtD
Citalopram—Gastrointestinal pain—Temozolomide—skin cancer	0.000104	0.000313	CcSEcCtD
Citalopram—Erythema—Docetaxel—skin cancer	0.000104	0.000312	CcSEcCtD
Citalopram—Malnutrition—Docetaxel—skin cancer	0.000104	0.000312	CcSEcCtD
Citalopram—Hypersensitivity—Dactinomycin—skin cancer	0.000104	0.000312	CcSEcCtD
Citalopram—Dyspepsia—Fluorouracil—skin cancer	0.000103	0.000311	CcSEcCtD
Citalopram—Decreased appetite—Fluorouracil—skin cancer	0.000102	0.000307	CcSEcCtD
Citalopram—Dysgeusia—Docetaxel—skin cancer	0.000101	0.000306	CcSEcCtD
Citalopram—CYP3A4—female reproductive system—skin cancer	0.000101	0.0118	CbGeAlD
Citalopram—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000101	0.000305	CcSEcCtD
Citalopram—Urticaria—Temozolomide—skin cancer	0.000101	0.000304	CcSEcCtD
Citalopram—Asthenia—Dactinomycin—skin cancer	0.000101	0.000304	CcSEcCtD
Citalopram—Body temperature increased—Temozolomide—skin cancer	0.000101	0.000303	CcSEcCtD
Citalopram—Abdominal pain—Temozolomide—skin cancer	0.000101	0.000303	CcSEcCtD
Citalopram—Back pain—Docetaxel—skin cancer	0.0001	0.000302	CcSEcCtD
Citalopram—Pain—Fluorouracil—skin cancer	0.0001	0.000302	CcSEcCtD
Citalopram—Muscle spasms—Docetaxel—skin cancer	9.96e-05	0.0003	CcSEcCtD
Citalopram—CYP2D6—female reproductive system—skin cancer	9.96e-05	0.0116	CbGeAlD
Citalopram—Feeling abnormal—Fluorouracil—skin cancer	9.65e-05	0.000291	CcSEcCtD
Citalopram—ABCB1—epithelium—skin cancer	9.64e-05	0.0112	CbGeAlD
Citalopram—Diarrhoea—Dactinomycin—skin cancer	9.62e-05	0.00029	CcSEcCtD
Citalopram—Vomiting—Bleomycin—skin cancer	9.58e-05	0.000289	CcSEcCtD
Citalopram—Anaemia—Docetaxel—skin cancer	9.58e-05	0.000288	CcSEcCtD
Citalopram—Rash—Bleomycin—skin cancer	9.5e-05	0.000286	CcSEcCtD
Citalopram—Dermatitis—Bleomycin—skin cancer	9.5e-05	0.000286	CcSEcCtD
Citalopram—Hypersensitivity—Temozolomide—skin cancer	9.37e-05	0.000282	CcSEcCtD
Citalopram—Urticaria—Fluorouracil—skin cancer	9.31e-05	0.00028	CcSEcCtD
Citalopram—Syncope—Docetaxel—skin cancer	9.29e-05	0.00028	CcSEcCtD
Citalopram—Leukopenia—Docetaxel—skin cancer	9.27e-05	0.000279	CcSEcCtD
Citalopram—Body temperature increased—Fluorouracil—skin cancer	9.26e-05	0.000279	CcSEcCtD
Citalopram—Palpitations—Docetaxel—skin cancer	9.16e-05	0.000276	CcSEcCtD
Citalopram—Asthenia—Temozolomide—skin cancer	9.12e-05	0.000275	CcSEcCtD
Citalopram—Loss of consciousness—Docetaxel—skin cancer	9.11e-05	0.000274	CcSEcCtD
Citalopram—Cough—Docetaxel—skin cancer	9.04e-05	0.000272	CcSEcCtD
Citalopram—Pruritus—Temozolomide—skin cancer	9e-05	0.000271	CcSEcCtD
Citalopram—Convulsion—Docetaxel—skin cancer	8.98e-05	0.00027	CcSEcCtD
Citalopram—Nausea—Bleomycin—skin cancer	8.95e-05	0.00027	CcSEcCtD
Citalopram—Hypertension—Docetaxel—skin cancer	8.95e-05	0.000269	CcSEcCtD
Citalopram—Vomiting—Dactinomycin—skin cancer	8.94e-05	0.000269	CcSEcCtD
Citalopram—Rash—Dactinomycin—skin cancer	8.86e-05	0.000267	CcSEcCtD
Citalopram—Arthralgia—Docetaxel—skin cancer	8.82e-05	0.000266	CcSEcCtD
Citalopram—Chest pain—Docetaxel—skin cancer	8.82e-05	0.000266	CcSEcCtD
Citalopram—Myalgia—Docetaxel—skin cancer	8.82e-05	0.000266	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	8.76e-05	0.000264	CcSEcCtD
Citalopram—Diarrhoea—Temozolomide—skin cancer	8.7e-05	0.000262	CcSEcCtD
Citalopram—Hypersensitivity—Fluorouracil—skin cancer	8.63e-05	0.00026	CcSEcCtD
Citalopram—Dry mouth—Docetaxel—skin cancer	8.63e-05	0.00026	CcSEcCtD
Citalopram—Confusional state—Docetaxel—skin cancer	8.53e-05	0.000257	CcSEcCtD
Citalopram—Anaphylactic shock—Docetaxel—skin cancer	8.46e-05	0.000255	CcSEcCtD
Citalopram—Oedema—Docetaxel—skin cancer	8.46e-05	0.000255	CcSEcCtD
Citalopram—Dizziness—Temozolomide—skin cancer	8.41e-05	0.000253	CcSEcCtD
Citalopram—Infection—Docetaxel—skin cancer	8.4e-05	0.000253	CcSEcCtD
Citalopram—ABCB1—mammalian vulva—skin cancer	8.36e-05	0.00976	CbGeAlD
Citalopram—Nausea—Dactinomycin—skin cancer	8.35e-05	0.000252	CcSEcCtD
Citalopram—Shock—Docetaxel—skin cancer	8.32e-05	0.000251	CcSEcCtD
Citalopram—CYP2D6—head—skin cancer	8.32e-05	0.0097	CbGeAlD
Citalopram—Nervous system disorder—Docetaxel—skin cancer	8.29e-05	0.00025	CcSEcCtD
Citalopram—Pruritus—Fluorouracil—skin cancer	8.29e-05	0.00025	CcSEcCtD
Citalopram—Thrombocytopenia—Docetaxel—skin cancer	8.28e-05	0.000249	CcSEcCtD
Citalopram—Tachycardia—Docetaxel—skin cancer	8.25e-05	0.000249	CcSEcCtD
Citalopram—Skin disorder—Docetaxel—skin cancer	8.21e-05	0.000247	CcSEcCtD
Citalopram—Vomiting—Temozolomide—skin cancer	8.08e-05	0.000244	CcSEcCtD
Citalopram—Anorexia—Docetaxel—skin cancer	8.06e-05	0.000243	CcSEcCtD
Citalopram—Rash—Temozolomide—skin cancer	8.02e-05	0.000242	CcSEcCtD
Citalopram—Diarrhoea—Fluorouracil—skin cancer	8.02e-05	0.000241	CcSEcCtD
Citalopram—Dermatitis—Temozolomide—skin cancer	8.01e-05	0.000241	CcSEcCtD
Citalopram—Headache—Temozolomide—skin cancer	7.97e-05	0.00024	CcSEcCtD
Citalopram—Hypotension—Docetaxel—skin cancer	7.9e-05	0.000238	CcSEcCtD
Citalopram—Dizziness—Fluorouracil—skin cancer	7.75e-05	0.000233	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Docetaxel—skin cancer	7.7e-05	0.000232	CcSEcCtD
Citalopram—HRH1—lymph node—skin cancer	7.65e-05	0.00893	CbGeAlD
Citalopram—Insomnia—Docetaxel—skin cancer	7.65e-05	0.00023	CcSEcCtD
Citalopram—Paraesthesia—Docetaxel—skin cancer	7.59e-05	0.000229	CcSEcCtD
Citalopram—Nausea—Temozolomide—skin cancer	7.55e-05	0.000228	CcSEcCtD
Citalopram—Dyspnoea—Docetaxel—skin cancer	7.54e-05	0.000227	CcSEcCtD
Citalopram—Somnolence—Docetaxel—skin cancer	7.52e-05	0.000226	CcSEcCtD
Citalopram—Vomiting—Fluorouracil—skin cancer	7.45e-05	0.000224	CcSEcCtD
Citalopram—Dyspepsia—Docetaxel—skin cancer	7.44e-05	0.000224	CcSEcCtD
Citalopram—ABCB1—lymphoid tissue—skin cancer	7.43e-05	0.00866	CbGeAlD
Citalopram—Rash—Fluorouracil—skin cancer	7.39e-05	0.000223	CcSEcCtD
Citalopram—Dermatitis—Fluorouracil—skin cancer	7.38e-05	0.000222	CcSEcCtD
Citalopram—Decreased appetite—Docetaxel—skin cancer	7.35e-05	0.000221	CcSEcCtD
Citalopram—Headache—Fluorouracil—skin cancer	7.34e-05	0.000221	CcSEcCtD
Citalopram—Gastrointestinal disorder—Docetaxel—skin cancer	7.3e-05	0.00022	CcSEcCtD
Citalopram—Fatigue—Docetaxel—skin cancer	7.29e-05	0.00022	CcSEcCtD
Citalopram—Constipation—Docetaxel—skin cancer	7.23e-05	0.000218	CcSEcCtD
Citalopram—Pain—Docetaxel—skin cancer	7.23e-05	0.000218	CcSEcCtD
Citalopram—ABCB1—female reproductive system—skin cancer	7.16e-05	0.00836	CbGeAlD
Citalopram—Feeling abnormal—Docetaxel—skin cancer	6.97e-05	0.00021	CcSEcCtD
Citalopram—Nausea—Fluorouracil—skin cancer	6.96e-05	0.00021	CcSEcCtD
Citalopram—Gastrointestinal pain—Docetaxel—skin cancer	6.91e-05	0.000208	CcSEcCtD
Citalopram—Abdominal pain—Docetaxel—skin cancer	6.68e-05	0.000201	CcSEcCtD
Citalopram—Body temperature increased—Docetaxel—skin cancer	6.68e-05	0.000201	CcSEcCtD
Citalopram—Hypersensitivity—Docetaxel—skin cancer	6.23e-05	0.000188	CcSEcCtD
Citalopram—Asthenia—Docetaxel—skin cancer	6.07e-05	0.000183	CcSEcCtD
Citalopram—ABCB1—head—skin cancer	5.98e-05	0.00698	CbGeAlD
Citalopram—Pruritus—Docetaxel—skin cancer	5.98e-05	0.00018	CcSEcCtD
Citalopram—Diarrhoea—Docetaxel—skin cancer	5.79e-05	0.000174	CcSEcCtD
Citalopram—Dizziness—Docetaxel—skin cancer	5.59e-05	0.000168	CcSEcCtD
Citalopram—Vomiting—Docetaxel—skin cancer	5.38e-05	0.000162	CcSEcCtD
Citalopram—Rash—Docetaxel—skin cancer	5.33e-05	0.000161	CcSEcCtD
Citalopram—Dermatitis—Docetaxel—skin cancer	5.33e-05	0.00016	CcSEcCtD
Citalopram—Headache—Docetaxel—skin cancer	5.3e-05	0.00016	CcSEcCtD
Citalopram—Nausea—Docetaxel—skin cancer	5.02e-05	0.000151	CcSEcCtD
Citalopram—ABCB1—lymph node—skin cancer	4.19e-05	0.00489	CbGeAlD
